دورية أكاديمية
أعرض في EDS

Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned.

التفاصيل البيبلوغرافية
العنوان: Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned.
المؤلفون: Fischer SE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alatise OI; Obafemi Awolowo University, Ile-Ife, Nigeria.; Surgeons Overseas, New York, NY, USA., Komolafe AO; Obafemi Awolowo University, Ile-Ife, Nigeria., Katung AI; Federal Medical Center, Owo, Nigeria., Egberongbe AA; Federal Medical Center, Owo, Nigeria., Olatoke SA; University of Ilorin Teaching Hospital, Ilorin, Nigeria., Agodirin OS; University of Ilorin Teaching Hospital, Ilorin, Nigeria., Kolawole OA; Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria., Olaofe OO; Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria., Ayandipo OO; University College Hospital, Ibadan, Nigeria., Rotimi O; St. James University Hospital, Leeds, UK., Brennan MF; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kingham TP; Memorial Sloan Kettering Cancer Center, New York, NY, USA. kinghamt@mskcc.org.; Surgeons Overseas, New York, NY, USA. kinghamt@mskcc.org.
المصدر: Annals of surgical oncology [Ann Surg Oncol] 2017 Mar; Vol. 24 (3), pp. 627-631. Date of Electronic Publication: 2016 Oct 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
مواضيع طبية MeSH: Developing Countries* , Neoplasms*, Biomedical Research/*organization & administration , Organizations/*organization & administration, Capacity Building ; Cooperative Behavior ; Humans ; International Cooperation ; Nigeria ; Organizations/economics ; Program Development ; Workforce
مستخلص: Purpose: There is an increasing effort in the global public health community to strengthen research capacity in low- and middle-income countries, but there is no consensus on how best to approach such endeavors. Successful consortia that perform research on HIV/AIDS and other infectious diseases exist, but few papers have been published detailing the challenges faced and lessons learned in setting up and running a successful research consortium.
Methods: Members of the African Research Group for Oncology (ARGO) participated in generating lessons learned regarding the foundation and maintenance of a cancer research consortium in Nigeria.
Results: Drawing on our experience of founding ARGO, we describe steps and key factors needed to establish a successful collaborative consortium between researchers from both high- and low-income countries. In addition, we present challenges we encountered in building our consortium, and how we managed those challenges. Although our research group is focused primarily on cancer, many of our lessons learned can be applied more widely in biomedical or public health research in low-income countries.
Conclusions: As the need for cancer care in LMICs continues to grow, the ability to create sustainable, innovative, collaborative research groups will become vital. Assessing the successes and failures that occur in creating and sustaining research consortia in LMICs is important for expansion of research and training capacity in LMICs.
References: J Clin Oncol. 2016 Jan 1;34(1):20-6. (PMID: 26578619)
Int J Drug Policy. 2016 Jan;27:132-7. (PMID: 26342275)
Pan Afr Med J. 2015 Apr 30;20:451. (PMID: 26309482)
PLoS Med. 2011 Sep;8(9):e1001068. (PMID: 21931538)
Lancet Oncol. 2015 Sep;16(11):1193-224. (PMID: 26427363)
Glob Health Action. 2012;5:. (PMID: 22566788)
Ann Surg Oncol. 2015 Mar;22(3):741-6. (PMID: 25572682)
PLoS Med. 2014 Mar 11;11(3):e1001612. (PMID: 24618823)
Glob Public Health. 2013;8 Suppl 1:S104-24. (PMID: 23651463)
Lancet. 2013 Sep 28;382(9898):1140-51. (PMID: 24075054)
PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3380. (PMID: 25569232)
Health Res Policy Syst. 2011 Mar 28;9:14. (PMID: 21443780)
Pan Afr Med J. 2014 Jan 18;17 Suppl 1:1. (PMID: 24624239)
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
EMBO Rep. 2004 Jan;5(1):7-11. (PMID: 14710175)
Lancet. 2008 Nov 1;372(9649):1590-3. (PMID: 18984193)
Infect Dis Clin North Am. 2011 Sep;25(3):511-36, vii. (PMID: 21896356)
Acad Med. 2007 Aug;82(8):812-8. (PMID: 17762264)
EMBO Rep. 2012 May;13(5):395. (PMID: 22473296)
معلومات مُعتمدة: P30 CA008748 United States CA NCI NIH HHS
تواريخ الأحداث: Date Created: 20161016 Date Completed: 20180223 Latest Revision: 20231112
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC5364494
DOI: 10.1245/s10434-016-5624-2
PMID: 27743225
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-4681
DOI:10.1245/s10434-016-5624-2